0001231919-24-000017.txt : 20240214 0001231919-24-000017.hdr.sgml : 20240214 20240214140714 ACCESSION NUMBER: 0001231919-24-000017 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 EFFECTIVENESS DATE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Graviton BioScience Corp CENTRAL INDEX KEY: 0001847048 ORGANIZATION NAME: IRS NUMBER: 851662151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-505280 FILM NUMBER: 24635905 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 332-400-0444 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001847048 Graviton BioScience Corp 125 West End Ave Suite 301 New York NY NEW YORK 10023 332-400-0444 DELAWARE None None Corporation true 2020 Bihua Chen c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director Samuel D Waksal c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Executive Officer Director Promoter Stelios Papadopoulos c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director Jeremy Levin c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director David MacMillan c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director Ran Nussbaum c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director James Boylan c/o Graviton BioScience Corporation 125 West End Ave, Suite 301 New York NY NEW YORK 10023 Director Biotechnology Decline to Disclose 06b false 2024-01-31 false true false 0 24999996 24999996 0 false 1 0 0 0 false Graviton BioScience Corp /s/Samuel D. Waksal Samuel D. Waksal Chief Executive Officer 2024-02-14